Search Results 21-30 of 11452 for Ibrance

  1. Cancer Clinical Trials - Medical Professionals

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  2. Cancer Clinical Trials - Medical Professionals

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  3. Cancer Clinical Trials - Medical Professionals

    Collection of blood to track serial circulating tumor cells (CTCs) in subjects with metastatic breast cancer (MBC). Study will also collect data from ...

  4. Capivasertib (Oral Route) Description and Brand Names - Mayo Clinic

    Capivasertib belongs to the group of medicines, called antineoplastics. It interferes with the growth of cancer cells, which are eventually destroyed.

  5. Aflibercept-Mrbb (Intraocular Route) Description and Brand Names - Mayo Clinic

    It is also used to treat diabetic macular edema (DME) and diabetic retinopathy. Macular edema is swelling in the back of the eye and may cause vision loss.

  6. Aflibercept-Yszy (Intraocular Route) Description and Brand Names - Mayo Clinic

    Aflibercept-yszy injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes ...

  7. Epirubicin (Intravenous Route) Description and Brand Names - Mayo Clinic

    Epirubicin injection is used together with other cancer medicines to treat breast cancer in patients who have had surgery to remove the tumor.

  8. Idelalisib (Oral Route) Description and Brand Names - Mayo Clinic

    Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (CLL) that has come back after other treatment. Idelalisib interferes ...

  9. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer - Mayo Clinic

    This is a multicenter, Phase 1b/2 trial. The purpose of phase 1b part of the trial aims to determine the recommended phase II dose (RP2D) of elacestrant when ...

  10. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab - Mayo Clinic

    Patients who with advanced breast cancer who have failed prior therapies will be eligible to enroll in this study. The study will evaluate SV-BR-1-GM in ...